X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

May 07, 2019

The Impact Poor Formulations Have on Drug Development Programs

<span>Before an injectable biologic can be formulated and manufactured, an extensive series of pre-formulation checks are necessary to ensure that developers avoid formulating an unstable, non-viable product&sup1;. Developers must determine whether the injectable biologic will break down within the intended formulation or the manufacturing process. The drug must be thermally stable, possibly resistant to oxidation, tolerate variations in light, and other environmental stresses placed on it during manufacturing and packaging.</span>
Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

Previous Posts
West on the Road Blog

November 13, 2017

West on the Road: Eschweiler, Germany - Part 2

Deirdre Swinden

Deirdre Swinden

Director, Marketing Communications

Sterilizable Bags

June 14, 2017

Aseptic Manufacturing: Packaging for Parenteral Packaging Components

Simon Cote

Simon Côté

Principal Engineer, Technical Customer Services

West logo with Diamond

January 31, 2017

West Obtains ISO 15378 Certification in North America

James Rigney

James Rigney

Manager, Quality North America

West on the Road Blog Card

June 30, 2016

West on the Road: Tempe, AZ – Part 1

West Pharma

West's Global Communications Team

Load more